Axsome Therapeutics (AXSM) Change in Inventory (2022 - 2026)

Axsome Therapeutics has reported Change in Inventory for 5 years, with the latest figure at $3.1 million in Q1 2026.

• Quarterly Change in Inventory rose 1149.0% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (up 2353.5% YoY) and the FY2025 annual result came in at $10.7 million, up 1532.8% from the prior year.
• Change in Inventory declined to $3.1 million in Q1 2026 per AXSM's latest filing, from $3.6 million in the prior quarter.
• Over five years, Change in Inventory peaked at $5.0 million in Q3 2025 and troughed at -$1.7 million in Q3 2023.
• A 5-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory tumbled 681.82% in 2023, then jumped 1149.0% in 2026.
• Over 5 years, Change in Inventory stood at $1.3 million in 2022, then surged by 269.74% to $4.9 million in 2023, then slumped by 76.9% to $1.1 million in 2024, then jumped by 222.41% to $3.6 million in 2025, then decreased by 14.56% to $3.1 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $3.1 million, $3.6 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.